NCT00076440 - Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Alzheimer Disease

Interventions

DRUG

Leuprolide acetate

Trial Locations (13)

Innovative Clinical Research Center, Alexandria

Medical University of South Carolina, Charleston

Baumel-Eisner Neuromedical Institute, Miami Beach

Baumel-Eisner Neuromedical Institute, Fort Lauderdale

Brain Matters Research, Delray Beach

Baumel-Eisner Neuromedical Institute, Boca Raton

Meridien Research, St. Petersburg

Middleton VA Wisconsin Alzheimer's Institute, Madison

Southwest Clinical Research, Rancho Mirage

Margolin Brain Institute, Fresno

Bay Area Research Institute, Lafayette

Geriatric and Adult Psychiatry LLC, Hamden

Boston University School of Medicine, Boston

All Listed Sponsors

lead

Voyager Pharmaceutical Corporation

INDUSTRY